✦ LIBER ✦

Long-term converting-enzyme inhibition as a guide to surgical curability of hypertension associated with renovascular disease

✍ Scribed by Jan Staessen; Christopher Bulpitt; Robert Fagard; Paul Lijnen; Antoon Amery

Book ID: 115670798
Publisher: Elsevier Science
Year: 1983
Tongue: English
Weight: 785 KB
Volume: 51
Category: Article
ISSN: 0002-9149
DOI: 10.1016/0002-9149(83)90305-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metabolic effects of long-term angiotens

Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition

✍ R. Reneland; P.-E. Andersson; A. Haenni; H. Lithell 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 566 KB

Fifty patients with mild to moderate essential hypertension were randomized to receive either 20 mg fosinopril daily for 16 weeks or placebo for 4 weeks followed by 12 weeks of 50 mg atenolol daily. Prior to these 16 weeks there was a placebo wash-out period of 2-6 weeks. Blood pressure measurements

Long-term efficacy of angiotensin-conver

Long-term efficacy of angiotensin-converting-enzyme inhibition with captopril in mild-to-moderate essential hypertension.

✍ KO Stumpe; A Overlack; R Kolloch; S Schreyer 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 844 KB